Accession Number: | 0000899243-21-022976 |
Date: | 2021-06-08 |
Issuer: | SCPHARMACEUTICALS INC. (SCPH) |
Original Submission Date: |
VEITINGER KLAUS R DR
C/O SCPHARMACEUTICALS INC, 2400
DISTRICT AVENUE, SUITE 310
BURLINGTON, MA 01803
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 5.7 | 2021-06-08 | deemed execution date | A | 16,300 (a) | 2031-06-08 | common stock 16,300 | $5.70 | 16,300 | direct |
ID | footnote |
---|---|
f1 | this stock option vests in full upon the earlier of (i) june 8, 2022, and (ii) the next annual meeting of the issuer's stockholders. |